Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

23 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Beclomethasone Nasal Articles

Rigel shares hit by R112's Ph II failure

12 December 2005

FDA gives Enteron's GVDH drug orphan status for new indication

28 September 2001

World OTC cough/cold/allergy products sales "set to grow 20% to 2008"

4 April 2000

GW & W-L Dissolve OTC Joint Venture

5 August 1998

FDA And GW Put Beconase OTC Switch On Hold

11 September 1997

Glaxo Wellcome 1996 Product Performance

17 March 1997

Glaxo Wellcome Sells OTC Business To Warner-Lambert

8 January 1996

Competition and Acquisition Pressure Hits Glaxo

19 September 1994

WARNER WELLCOME JV SETS SIGHTS ON TOP SPOT

6 June 1994

UK INDUSTRY REPORT ON "BRIBERY" CHARGES

21 March 1994

GLAXO SEES 25% INTERIM TRADING PROFIT RISE

21 February 1994

OTC BECONASE TO BECOME AVAILABLE

14 February 1994

WORLD RESPIRATORY PRODUCTS MARKET

1 March 1993

Showing 1-13 of 13 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Italy's pharma market slump set to continue, warns GlobalData
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Italy's pharma market slump set to continue, warns GlobalData
  • Is failure to adopt business process management putting the pharma industry at risk?

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS